Viral-associated lymphoid proliferations

Seminars in Diagnostic Pathology

Volumn 30, Issue 2, 2013, Pages 130-136

  Pittaluga, Stefania ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Chronic active EBV; EBV; HHV6; Lymphoid proliferation

Indexed keywords

CD15 ANTIGEN; CD20 ANTIGEN; CD30 ANTIGEN; MEMBRANE COFACTOR PROTEIN;

AGE; ARTICLE; CD4 CD8 RATIO; CELLULAR IMMUNITY; CHRONIC ACTIVE EPSTEIN BARR VIRUS INFECTION; CLINICAL FEATURE; DISEASE ASSOCIATION; ELECTRON MICROSCOPY; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; FAMILY HISTORY; HERPES VIRUS INFECTION; HISTOPATHOLOGY; HUMAN; HUMAN HERPESVIRUS 6; LYMPHADENITIS; LYMPHOPROLIFERATIVE DISEASE; MEDICAL HISTORY; MONONUCLEOSIS; NONHUMAN; PRIORITY JOURNAL; VIRUS DETECTION; VIRUS LATENCY; VIRUS TRANSMISSION;

HUMANS; LYMPHOPROLIFERATIVE DISORDERS; VIRUS DISEASES;

EID: 84879845331     PISSN: 07402570     EISSN: 19301111     Source Type: Journal    
DOI: 10.1053/j.semdp.2012.08.009     Document Type: Article

References (33)

1. Cohen J.I. Epstein-Barr virus infection. N. Engl. J. Med. 2000, 343(7):481-492.
2. Rickinson A.B., Kieff E. Epstein-Barr Virus 2007, Lippincott Williams & Wilkins, Philadelphia. 5th ed.
3. Thorley-Lawson D.A. Epstein-Barr virus: exploiting the immune system. Nat. Rev. Immunol. 2001, 1(1):75-82.
4. Roughan J.E., Torgbor C., Thorley-Lawson D.A. Germinal center B cells latently infected with Epstein-Barr virus proliferate extensively but do not increase in number. J. Virol. 2010, 84(2):1158-1168.
5. Kalla M., Hammerschmidt W. Human B cells on their route to latent infection-early but transient expression of lytic genes of Epstein-Barr virus. Eur. J. Cell Biol. 2011.
6. Bharadwaj M., Burrows S.R., Burrows J.M., Moss D.J., Catalina M., Khanna R. Longitudinal dynamics of antigen-specific CD8+ cytotoxic T lymphocytes following primary Epstein-Barr virus infection. Blood 2001, 98(8):2588-2589.
7. Callan M.F., Steven N., Krausa P., et al. Large clonal expansions of CD8+ T cells in acute infectious mononucleosis. Nat Med 1996, 2(8):906-911.
8. Callan M.F. The evolution of antigen-specific CD8+ T cell responses after natural primary infection of humans with Epstein-Barr virus. Viral Immunol. 2003, 16(1):3-16.
9. Iwakiri D., Takada K. Role of EBERs in the pathogenesis of EBV infection. Adv. Cancer Res. 2010, 107:119-136.
10. Niedobitek G., Hamilton-Dutoit S., Herbst H., et al. Identification of Epstein-Barr virus-infected cells in tonsils of acute infectious mononucleosis by in situ hybridization. Hum. Pathol. 1989, 20(8):796-799.
11. Hudnall S.D., Ge Y., Wei L., Yang N.P., Wang H.Q., Chen T. Distribution and phenotype of Epstein-Barr virus-infected cells in human pharyngeal tonsils. Mod. Pathol. 2005, 18:519-527.
12. Niedobitek G., Herbst H., Young L.S., et al. Patterns of Epstein-Barr virus infection in non-neoplastic lymphoid tissue. Blood 1992, 79(10):2520-2526.
13. Straus S.E. The chronic mononucleosis syndrome. J. Infect Dis 1988, 157(3):405-412.
14. Kimura H., Hoshino Y., Kanegane H., et al. Clinical and virologic characteristics of chronic active Epstein-Barr virus infection. Blood 2001, 98(2):280-286.
15. Cohen J.I., Kimura H., Nakamura S., Ko Y.H., Jaffe E.S. Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8-9 September 2008. Ann. Oncol 2009, 20(9):1472-1482.
16. Cohen J.I., Jaffe E.S., Dale J.K., et al. Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States. Blood 2011, 117(22):5835-5849.
17. Kimura H. Pathogenesis of chronic active Epstein-Barr virus infection: is this an infectious disease, lymphoprolifertaive disorder, or immunodeficiency?. Rev. Med. Virol. 2006, 16:251-261.
18. Kimura H., Morishima T., Kanegane H., et al. Prognostic factors for chronic active Epstein-Barr virus infection. J. Infect. Dis. 2003, 187(4):527-533.
19. Ohshima K., Kimura H., Yoshino T., et al. Proposed categorization of pathological states of EBV-associated T/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD. Pathol. Inter. 2008, 58(4):209-217.
20. Quintanilla-Martinez L., Kumar S., Fend F., et al. Fulminant EBV(+) T-cell lymphoproliferative disorder following acute/chronic EBV infection: a distinct clinicopathologic syndrome. Blood 2000, 96(2):443-451.
21. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissue 2008, IARC, Lyon.
22. Barrionuevo C., Anderson V.M., Zevallos-Giampietri E., et al. Hydroa-like cutaneous T-cell lymphoma: a clinicopathologic and molecular genetic study of 16 pediatric cases from Peru. App. Immunohistochem. Mol. Morphol. 2002, 10(1):7-14.
23. Satoh M., Oyama N., Akiba H., Ohtsuka M., Iwatsuki K., Kaneko F. Hypersensitivity to mosquito bites with natural-killer cell lymphocytosis: the possible implication of Epstein-Barr virus reactivation. Eur. J. Dermatol. 2002, 12(4):381-384.
24. Rodriguez-Pinilla S.M., Barrionuevo C., Garcia J., et al. EBV-associated cutaneous NK/T-cell lymphoma: review of a series of 14 cases from Peru in children and young adults. Am. J. Surg. Pathol. 2010, 34(12):1773-1782.
25. Brunner S., Herndler-Brandstetter D., Weinberger B., Grubeck-Loebenstein B. Persistent viral infections and immune aging. Ageing Res. Rev. 2010.
26. Oyama T., Ichimura K., Suzuki R., et al. Senile EBV+ B-cell lymphoproliferative disorders: a clinicopathologic study of 22 patients. Am. J. Surg. Pathol. 2003, 27(1):16-26.
27. Oyama T., Yamamoto K., Asano N., et al. Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: a study of 96 patients. Clin. Cancer Res. 2007, 13(17):5124-5132.
28. Dojcinov S.D., Venkataraman G., Raffeld M., Pittaluga S., Jaffe E.S. EBV positive mucocutaneous ulcer-a study of 26 cases associated with various sources of immunosuppression. Am. J. Surg. Pathol. 2010, 34(3):405-417.
29. Dojcinov S.D., Venkataraman G., Pittaluga S., et al. Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma. Blood 2011, 117(18):4726-4735.
30. Asano N., Yamamoto K., Tamaru J., et al. Age-related Epstein-Barr virus (EBV)-associated B-cell lymphoproliferative disorders: comparison with EBV-positive classic Hodgkin lymphoma in elderly patients. Blood 2009, 113(12):2629-2636.
31. Dockrell D.H. Human herpesvirus 6: molecular biology and clinical features. J. Med. Microbiol 2003, 52(Pt 1):5-18.
32. Santoro F., Kennedy P.E., Locatelli G., Malnati M.S., Berger E.A., Lusso P. CD46 is a cellular receptor for human herpesvirus 6. Cell 1999, 99(7):817-827.
33. Maric I., Bryant R., Abu-Asab M., et al. Human herpesvirus-6-associated acute lymphadenitis in immunocompetent adults. Mod. Pathol. 2004, 17(11):1427-1433.